$KURA:NASDAQ · Kura Oncology, Inc.

Conviction from: NASDAQ

Precision oncology clinical-stage biotech

Not currently held by tracked 13F filers — this page aggregates activist, insider, politician and research activity.

Beyond 13F — activists, insiders, politicians & research

Filed	Insider	Role	Shares	Value
2026-08-24	WILSON TROY EDWARD	director+officer	100,000	$1,239,000	Form 4
2026-08-17	WILSON TROY EDWARD	director+officer	100,000	$1,112,000	Form 4

from2028 — cross-site stock view. Rebuilt at publish time.